» Articles » PMID: 35207767

Age-Related Changes in Lipid and Glucose Levels Associated with Drug Use and Mortality: An Observational Study

Overview
Journal J Pers Med
Date 2022 Feb 25
PMID 35207767
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The pathogenesis of type 2 diabetes mellitus is complex and still unclear in some details. The main feature of diabetes mellitus is high serum glucose, and the question arises of whether there are other statistically observable dysregulations in laboratory measurements before the state of hyperglycemia becomes severe. In the present study, we aim to examine glucose and lipid profiles in the context of age, sex, medication use, and mortality.

Methods: We conducted an observational study by analyzing laboratory data from 506,083 anonymized laboratory tests from 63,606 different patients performed by a regional laboratory in Slovenia between 2008 and 2019. Laboratory data-based results were evaluated in the context of medication use and mortality. The medication use database contains anonymized records of 1,632,441 patients from 2013 to 2018, and mortality data were obtained for the entire Slovenian population.

Results: We show that the highest percentage of the population with elevated glucose levels occurs approximately 20 years later than the highest percentage with lipid dysregulation. Remarkably, two distinct inflection points were observed in these laboratory results. The first inflection point occurs at ages 55 to 59 years, corresponding to the greatest increase in medication use, and the second coincides with the sharp increase in mortality at ages 75 to 79 years.

Conclusions: Our results suggest that medications and mortality are important factors affecting population statistics and must be considered when studying metabolic disorders such as dyslipidemia and hyperglycemia using laboratory data.

Citing Articles

PROGNOSTIC VALUES OF LIPID PANEL DATA FOR MACROVASCULAR COMPLICATION DEVELOPMENT IN TYPE 2 DIABETIC PATIENTS WITH COMORBID THYROID DYSFUNCTION.

Marushchak M, Krynytska I, Gashynska O, Yakymchuk O Acta Clin Croat. 2025; 63(1):89-100.

PMID: 39959321 PMC: 11827394. DOI: 10.20471/acc.2024.63.01.11.


Oral Corticosteroids for Skin Disease in the Older Population: Minimizing Potential Adverse Effects.

Sparling K, Butler D Drugs Aging. 2024; 41(10):795-808.

PMID: 39285122 DOI: 10.1007/s40266-024-01143-8.


An exploration on the machine-learning-based stroke prediction model.

Zhi S, Hu X, Ding Y, Chen H, Li X, Tao Y Front Neurol. 2024; 15:1372431.

PMID: 38742047 PMC: 11089140. DOI: 10.3389/fneur.2024.1372431.


eHealth profile of patients with diabetes.

Jendly M, Santschi V, Tancredi S, Konzelmann I, Raboud L, Chiolero A Front Public Health. 2023; 11:1240879.

PMID: 37655284 PMC: 10466783. DOI: 10.3389/fpubh.2023.1240879.


Profiling of patients with type 2 diabetes based on medication adherence data.

Markovic R, Grubelnik V, Zavrsnik T, Blazun Vosner H, Kokol P, Perc M Front Public Health. 2023; 11:1209809.

PMID: 37483941 PMC: 10358769. DOI: 10.3389/fpubh.2023.1209809.


References
1.
Ko D, Mamdani M, Alter D . Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. JAMA. 2004; 291(15):1864-70. DOI: 10.1001/jama.291.15.1864. View

2.
Cho G, Yim J, Choi Y, Ko J, Lee S . Review of Machine Learning Algorithms for Diagnosing Mental Illness. Psychiatry Investig. 2019; 16(4):262-269. PMC: 6504772. DOI: 10.30773/pi.2018.12.21.2. View

3.
Ali M, Aittokallio T . Machine learning and feature selection for drug response prediction in precision oncology applications. Biophys Rev. 2018; 11(1):31-39. PMC: 6381361. DOI: 10.1007/s12551-018-0446-z. View

4.
McGarry J . Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 2002; 51(1):7-18. DOI: 10.2337/diabetes.51.1.7. View

5.
Shafrir E, Raz I . Diabetes: mellitus or lipidus?. Diabetologia. 2003; 46(3):433-40. DOI: 10.1007/s00125-003-1052-5. View